Habib J. Dable - 23 Jun 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role: Director
Signature: /s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol: BPMC
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2022, 18:45:52 UTC
Previous filing: 22 Nov 2021
Next filing: 10 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BPMC	Common Stock	Award	$0	+3,900		$0.000000	3,900	23 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BPMC	Stock Option (Right to Buy)	Award	$0	+7,950		$0.000000	7,950	23 Jun 2022	Common Stock	7,950	$56.38	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction involved the Reporting Person's receipt of a grant of 3,900 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
F2	This option vests with respect to 1/36th of the shares underlying the option on July 23, 2022 and as to an additional 1/36th of the shares underlying the option each month thereafter.